Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand Eczema.
controlled
EVIDENCE COMPARISON
DirectionalDelgocitinib
vs Dupilumab
for Redness Reduction
Early or indirect evidence suggests delgocitinib may reduce redness slightly more effectively than dupilumab for improving skin tone.
1.10x
Effect ratio
Delgocitinib
Favored
1
Study
Direct
Comparison
ExploratorySubjective endpointTone
Limits: Includes subjective endpoint · Early-stage evidence tier
How to read this claim
Kept public as exploratory because it includes subjective endpoint; early-stage evidence tier.
Some study-specific context may affect how broadly this comparison generalizes.